Traumatic optic neuropathy (TON) is a condition in which a strong blow to the forehead or frontal region, especially the eyebrow area, causes transmitted force (force that propagates rather than direct impact) to act on the optic canal, resulting in contusion of the optic nerve. Importantly, it is not necessarily associated with optic canal fracture; severe optic nerve damage can occur even in cases without fracture.
Typically, it develops after blunt trauma to the superolateral eyebrow area, so most cases show subcutaneous hemorrhage or contusion lacerations on the lateral side of the eyebrow.
TON is reported to occur in 0.5–5% of all head injuries. Common mechanisms include traffic accidents, sports injuries, and falls, with a typical pattern of blunt trauma to the superolateral brow. Only a minority of cases show optic canal deformity on plain X-ray or CT.
In the 2021 Beirut port explosion, 39 patients (48 eyes) were evaluated ophthalmologically. Orbital fractures were found in 14 eyes (29.2%), open globe injuries in 10 eyes (20.8%), and 53.8% required surgical intervention 1). Explosive trauma can also cause TON (see “Causes and Risk Factors” section for blast-induced traumatic optic neuropathy).
QHow is traumatic optic neuropathy different from optic nerve head avulsion?
A
Traumatic optic neuropathy is a condition in which the optic nerve is damaged at the optic canal due to indirect force from blunt trauma to the brow area. In contrast, optic nerve head avulsion is a severe injury where the optic nerve is physically torn at the level of the lamina cribrosa, and the avulsion site can be seen on fundus examination immediately after injury. A key distinguishing feature is that the fundus is usually normal immediately after injury in traumatic optic neuropathy.
GCC thickness becomes thinner and falls below normal range
6–8 weeks after injury and later
Progressive optic atrophy and optic disc pallor
GCC thickness stabilizes around 30–50 days
Relative afferent pupillary defect (RAPD) is the most important objective finding in unilateral or asymmetric bilateral cases, and is confirmed as Marcus-Gunn pupil (positive swinging flashlight test in the affected eye).
QCan traumatic optic neuropathy be ruled out even if the fundus is normal immediately after injury?
A
It cannot be ruled out. Immediately after injury, the fundus is often normal. Optic atrophy and optic disc pallor appear 6–8 weeks after injury, and thinning of GCC thickness on OCT is observed from about 2 weeks after injury. A normal fundus immediately after injury is not grounds for excluding the diagnosis; functional assessments such as RAPD (swinging flashlight test) are important.
Blunt trauma to the superolateral brow is the most common mechanism of injury. The impact propagates through the optic canal, causing vasogenic edema within the optic nerve parenchyma (see Pathophysiology section for details on pathophysiology).
Main causes:
Traffic accidents: Most common. Contact with windshield, airbag, or steering wheel.
Sports injuries: Collision with racket, ball, or ground.
Falls: Impact of face or forehead with the ground.
Assault: Direct blunt force to the face from fists or blunt objects.
Shock waves from blast overpressure propagate through ocular structures to the optic nerve, causing shear forces and stress that damage optic nerve fibers. It is characterized by the absence of penetrating injury or significant blunt trauma, and optic neuropathy can occur even without visible external signs of injury.
Military personnel, emergency responders, and civilians exposed to explosives are at high risk.
65–68% of blast-injured soldiers with traumatic brain injury (TBI) report visual problems.
Animal models have confirmed a dose-response relationship between total blast exposure and the degree of optic nerve degeneration.
Elevation of IL-1α and IL-1β in the optic nerve and retina has been demonstrated in animal models.
Gómez Roselló E, Quiles Granado AM, Artajona Garcia M, et al. Facial fractures: classification and highlights for a useful report. Insights Imaging. 2020;11(1):49. Figure 2. PMID: 32193796; PMCID: PMC7082488; DOI: 10.1186/s13244-020-00847-w. License: CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/).
Axial non-contrast CT of the orbit shows (a) hematoma at the posterior pole of the globe extending to the optic disc (arrowhead) and (b) bone fragment within the muscle cone causing optic nerve injury (black arrow: bone fragment, white arrow: optic nerve transection).
The most important test for diagnosing optic neuropathy is the swinging flashlight test. In the affected eye, the pupil dilates when light is shone, confirming a positive relative afferent pupillary defect (RAPD) (Marcus Gunn pupil). Even if visual acuity and fundus findings are good, this finding indicates the presence of optic nerve injury.
The following tests are used in combination for evaluation.
QIs it possible to have traumatic optic neuropathy even with good visual acuity?
A
Yes. In traumatic optic neuropathy, even if visual acuity is relatively preserved, visual field abnormalities, decreased contrast sensitivity, color vision abnormalities, and positive RAPD may be present. Evaluation using only high-contrast visual acuity risks missing the impairment. Assessment with RAPD (swinging flashlight test) is essential.
Evaluate visual function and associated orbital and head injuries early, and assess whether there is direct compression from bone fragments or a hematoma. Especially in indirect TON, there is no consensus on whether steroid therapy, optic canal decompression, or observation should be prioritized, and no clear superiority of pharmacotherapy or surgery has been established4)10). The following distinguishes treatment objectives from methods used in studies.
Pharmacotherapy
Example of steroid therapy: In a randomized controlled trial by Entezari et al., 31 patients injured within 7 days were studied; 16 patients in the treatment group received intravenous methylprednisolone 250 mg every 6 hours for 3 days, followed by oral prednisolone 1 mg/kg for 14 days. At 3 months, visual acuity and the rate of visual improvement did not differ significantly from those in the 15-patient placebo group11). This was the regimen used in the trial and does not indicate a uniform recommended dose or duration.
Example of combination therapy with a hyperosmotic agent: Hokazono et al. combined mannitol with steroid administration after decompression surgery in one case of optic canal fracture with optic nerve compression by a bone fragment12). This was a case report of combination treatment including surgery and does not support the effect of mannitol alone or routine combination therapy for TON in general.
Surgical Treatment
Optic canal decompression: There is much controversy regarding the indications for open surgery. Many believe that reducing edema within the optic nerve parenchyma is difficult to achieve surgically, except in cases where the optic nerve is clearly compromised due to marked deformation of the optic canal or significant displacement of bone fragments.
Transnasal endoscopic approach: In recent years, a minimally invasive transnasal endoscopic approach has become feasible.
Limited indications: Cases with marked deformation of the optic canal or significant displacement of bone fragments are considered appropriate for surgery.
Severe cases where loss of light perception does not recover quickly: These cases tend to respond poorly to treatment.
Longitudinal evaluation: Track changes in visual acuity, visual fields, and optic atrophy. The visual function improvement effect of pharmacotherapy in cases where time has elapsed since injury has also not been established4)10).
Spontaneous recovery: In general traumatic optic neuropathy, spontaneous recovery is reported in a certain proportion of cases, and prognosis is considered better in children than in adults.
Findings from IONTS (International Optic Nerve Trauma Study)
The IONTS compared steroid therapy, optic canal decompression, and observation, and none showed a significant advantage over the others2). Treatment selection should be individualized based on the patient’s general condition, severity of injury, and presence of fractures.
QHow effective is steroid treatment?
A
Especially in indirect TON, an effect superior to observation has not been established10). A randomized controlled trial of 31 patients examined intravenous methylprednisolone followed by oral prednisolone, but found no significant difference from placebo in visual improvement at 3 months11). Because spontaneous recovery also occurs, improvement after treatment alone cannot be used to determine the drug’s effectiveness2)3).
The effectiveness of high-dose steroids remains under debate. In addition to reports since IONTS finding no significant difference in visual function outcomes among untreated, steroid, and optic canal decompression groups, a Cochrane systematic review also found no clear effectiveness of steroids for traumatic optic neuropathy3). Recent systematic reviews have likewise concluded that high-quality evidence is scarce for steroids, surgery, and observation4). Furthermore, in the MRC CRASH trial of head injuries, mortality was reported to increase significantly in the methylprednisolone group, requiring cautious decisions about administration while considering the presence or absence of associated head injuries5)6).
Endoscopic transnasal optic canal decompression may be selected as a minimally invasive procedure, but further data are needed regarding indications and long-term outcomes. A tendency toward higher improvement rates with surgery early after injury, particularly within 3 days, has been reported7). On the other hand, meta-analyses comparing surgical decompression with conservative treatment have yielded inconsistent results, and randomized controlled trials have not been established8)9).
The main cause of optic nerve damage is thought to be vasogenic edema within the optic nerve parenchyma (tissue corresponding to the white matter of the brain) caused by blunt trauma. This is similar to brain edema after head trauma, and direct damage to optic nerve fibers in the optic canal due to hematoma or bone fragments is relatively rare.
This vasogenic edema compresses the optic nerve within the bony optic canal, leading to impaired blood flow, ischemia, and axonal damage through a mechanism similar to compartment syndrome.
Shock waves generated by blast overpressure propagate through ocular structures, causing shear stress on optic nerve fibers. This leads to traumatic axonal injury, progressing to neuroinflammation and functional impairment. While macroscopic damage is absent, axonal injury, gliosis, and inflammation occur at the tissue level.
Animal models (Rex et al.) have confirmed the following:
Transient elevation of intraocular pressure is induced
Death of retinal ganglion cells (RGCs) and axonal degeneration of the entire optic nerve occur
IL-1α and IL-1β are selectively elevated in the optic nerve and retina (other cytokines remain unchanged)
There is a dose-response relationship between the number of blast exposures and the degree of neurodegeneration
In a pilot study by Kashkouli et al., administration of EPO to patients with traumatic optic neuropathy was reported to improve visual outcomes. Direct application to blast-induced cases requires further research.
Research targeting enhancement of neuroprotective and neuroregenerative factors, and suppression of neurodegeneration and inflammatory factors is currently ongoing, and future clinical application is expected.
Blast-induced traumatic optic neuropathy (Blast-Induced Traumatic Optic Neuropathy; BON) is a subtype of traumatic optic neuropathy (TON). It is characterized by damage to the optic nerve caused by shock waves transmitted through the eye structures after exposure to blast overpressure, without penetrating injury or major blunt trauma.
A study reported that about 20% of military personnel injured by an explosion showed signs of ocular trauma between 2 weeks and 7 years after injury (2011).
In cases with concomitant traumatic brain injury (TBI), visual function abnormalities such as binocular vision, visual fields, and eye movements are frequently observed even when visual acuity is relatively preserved 1.
In animal models, a dose-response relationship has been confirmed between the total number of blast exposures and the degree of neurodegeneration of the optic nerve2.
QHow does blast-induced traumatic optic neuropathy (BON) differ from ordinary traumatic optic neuropathy (TON)?
A
Traumatic optic neuropathy is often triggered by blunt trauma such as traffic accidents or by penetrating injury, but blast-induced traumatic optic neuropathy is characterized by optic nerve damage caused only by the blast shock wave, without penetrating injury or major blunt trauma. Optic nerve dysfunction can occur even when there are no visible external signs of injury.
The following findings may be observed. Note that even if high-contrast visual acuity is preserved, multiple functional abnormalities may still be present.
delayed conduction of electrical activity in the visual system
reduced spatial contrast sensitivity
may show abnormalities even when high-contrast visual acuity is normal
The optic disc initially shows edema and eventually progresses to optic atrophy and loss of the RNFL on OCT. Cockerham et al. recommend a comprehensive evaluation that includes not only high-contrast visual acuity but also spatial contrast sensitivity, visual field testing, and color vision1. In the VFQ-25 survey, the quality of life of veterans exposed to blasts was shown to be significantly lower than that of healthy people and patients with diabetes, glaucoma, and multiple sclerosis3.
QCan blast-induced traumatic optic neuropathy still be possible even if visual acuity is good?
A
Yes. Even when high-contrast visual acuity is preserved, visual field abnormalities, reduced spatial contrast sensitivity, and color misidentification can occur. Evaluation based only on high-contrast visual acuity risks missing the impairment.
A shock wave from blast overpressure is transmitted through the eye structures to the optic nerve, where shear forces and stress damage the optic nerve fibers. The essential difference from other traumatic optic neuropathies is that it occurs without penetrating injury or direct blunt trauma.
Occupational exposure: military personnel, emergency responders, explosives handlers
Proximity to the blast source: closeness to IEDs (improvised explosive devices) and large weapons
Blast overpressure intensity: the greater the overpressure, the higher the risk of injury
Repeated exposure: a dose-response relationship has been shown in animal models
Coexisting traumatic brain injury or post-concussion syndrome: increases the rate of visual function impairment
QHow can the risk of blast-induced traumatic optic neuropathy be reduced?
A
Wearing protective gear (specialized eyewear and a helmet) is fundamental. Repeated exposure has been shown in animal models to have a dose-response relationship with neurodegeneration, so limiting the number of exposures is also an important preventive measure.
Diagnosis of blast-induced traumatic optic neuropathy requires a comprehensive medical history and a multifaceted examination. Ask in detail about proximity to the blast site, duration of exposure, use of protective gear, any pre-existing eye disease, and whether traumatic brain injury is present.
Clinical tests
Visual acuity test: Measures high-contrast visual acuity. Even if it is good, other functional abnormalities may still be present.
Pupillary response (RAPD): An important objective finding in unilateral or bilaterally asymmetric cases.
Eye movements: Necessary to rule out associated injuries.
OCT: Noninvasively detects thinning of the RNFL (retinal nerve fiber layer) and changes in the optic disc.
OCT-A: In indirect traumatic optic neuropathy, time-dependent thinning of the retinal layers and reduced microvascular density have been reported, and a similar pattern is suggested in blast-induced traumatic optic neuropathy.
Orbital CT: Used to rule out fractures of the optic canal, bone fragments, and optic nerve sheath hematoma.
MRI: Used to rule out surgically treatable lesions (canal fracture, sheath hematoma).
Visual quality-of-life assessment (VFQ-25 + NOS): Used by Lemke et al. to assess vision-related quality of life in blast-exposed veterans. Quality of life was reported to be significantly lower than in healthy people and in patients with diabetes, glaucoma, and multiple sclerosis3.
Optic neuritis: an inflammatory disease caused by autoimmune mechanisms. It presents with sudden unilateral vision loss and eye pain, and association with multiple sclerosis and neuromyelitis optica should be noted. Uhthoff’s phenomenon (temporary vision worsening after bathing or exercise) is characteristic
There are no guidelines specific to blast-induced traumatic optic neuropathy. There is also insufficient consensus on the medical treatment of traumatic optic neuropathy, and at present supportive care is the mainstay of treatment.
These are used in traumatic optic neuropathy cases, but their therapeutic role in blast-induced traumatic optic neuropathy is debated. In comparisons of intravenous dexamethasone and methylprednisolone, no significant difference in visual outcomes has been found.
The prognosis varies and depends on the severity of the initial injury, the effectiveness of treatment, and the individual’s response.
Spontaneous recovery has been reported in 15–30% of general traumatic optic neuropathy cases
About 40% of children with traumatic optic neuropathy show spontaneous improvement in vision
Because it does not involve physical trauma, blast-induced traumatic optic neuropathy may have a better overall prognosis than traumatic optic neuropathy, but the evidence directly supporting this is currently insufficient.
In the VFQ-25 survey, the quality of life of people exposed to blasts was lower than that of many patients with chronic eye diseases.
QIs there an established standard treatment for blast-induced traumatic optic neuropathy?
A
There are no guidelines specific to this disease. There is also insufficient consensus on the treatment of traumatic optic neuropathy, and at present supportive care (intraocular pressure control, inflammation control, and visual rehabilitation) is the main approach. Corticosteroids are sometimes used, but their effectiveness remains debated.
The shock wave generated by blast overpressure propagates through the ocular structures and creates shear forces and stress on the optic nerve fibers. This causes shear axonal injury and leads to neuroinflammation and functional impairment. No gross injury is seen, but at the tissue level there is axonal injury, gliosis, and inflammation.
The ganglion cell layer, inner nuclear layer, and the optic nerve are considered particularly vulnerable structures (Wang et al.).
In mouse models by Bernardo-Colón et al. and Rex et al. (experiments in which pressurized air was applied directly to the eye), the following findings were revealed2.
Transient increase in intraocular pressure is induced
Death of retinal ganglion cells (RGCs) and axonal degeneration throughout the optic nerve occur
Impairment of anterograde axonal transport to the superior colliculus appears first in the projection area of the peripheral retina
Increase in the glial area of the optic nerve (temporary changes in astrocytic tissue)
IL-1α and IL-1β increase in the optic nerve and retina (no change in other cytokines)
In another blast TBI rodent model by Mohan et al., reduced pupillary light reflex, biphasic pERG abnormalities (an acute decline within 24 hours and a chronic decline at 4 months), and RNFL thinning at 3 months were also confirmed, and focal loss of the ganglion cell layer and optic nerve injury were pathologically supported4.
Pathological comparison with other optic neuropathies
In a pilot study by Kashkouli et al., intravenous recombinant human EPO was given for 3 consecutive days to 7 patients with indirect traumatic optic neuropathy, and final visual acuity was reported to improve significantly compared with 8 patients in the observation group (p=0.012)5. Direct application to blast-induced traumatic optic neuropathy will require further study.
In a mouse model by Naguib et al., the group that received intravitreal buffer injection on day 1 after closed injury showed reduced ERG, worsening optic nerve damage, and persistent increases in inflammatory cytokines (IL-1α and IL-1β)6. Administration in the acute phase may be harmful, so timing must be considered carefully.
Thomas et al. evaluated anti-caspase-2 siRNA in a bITON mouse model; pre-blast administration showed a tendency to protect nerve fibers, but post-blast administration worsened intraocular inflammation and did not produce neuroprotective effects7.
Research is ongoing on strengthening neuroprotective and neuroregenerative factors and suppressing neurodegenerative and inflammatory factors.
Blanch RJ, Joseph IJ, Cockerham K. Traumatic optic neuropathy management: a systematic review. Eye (Lond). 2024;38(12):2312-2318. PMID:38862644.
Roberts I, Yates D, Sandercock P, et al; CRASH trial collaborators. Effect of intravenous corticosteroids on death within 14 days in 10008 adults with clinically significant head injury (MRC CRASH trial): randomised placebo-controlled trial. Lancet. 2004;364(9442):1321-1328. PMID:15474134.
Steinsapir KD, Goldberg RA. Traumatic optic neuropathy: an evolving understanding. Am J Ophthalmol. 2011;151(6):928-933.e2. PMID:21529765.
Yu B, Ma Y, Tu Y, Wu W. The Outcome of Endoscopic Transethmosphenoid Optic Canal Decompression for Indirect Traumatic Optic Neuropathy with No-Light-Perception. J Ophthalmol. 2016;2016:6492858. PMID:27965891.
Martinez-Perez R, Albonette-Felicio T, Hardesty DA, Carrau RL, Prevedello DM. Outcome of the surgical decompression for traumatic optic neuropathy: a systematic review and meta-analysis. Neurosurg Rev. 2021;44(2):633-641. PMID:32088777.
Fallahzadeh M, Veisi A, Tajari F, et al. The Management of Traumatic Optic Neuropathy: A Systematic Review and Meta-Analysis. Arch Acad Emerg Med. 2024;13(1):e19. PMID:39670238.
Wladis EJ, Aakalu VK, Sobel RK, et al. Interventions for Indirect Traumatic Optic Neuropathy: A Report by the American Academy of Ophthalmology. Ophthalmology. 2021;128(6):928-937. doi:10.1016/j.ophtha.2020.10.038. PMID:33161071.
Entezari M, Rajavi Z, Sedighi N, Daftarian N, Sanagoo M. High-dose intravenous methylprednisolone in recent traumatic optic neuropathy; a randomized double-masked placebo-controlled clinical trial. Graefes Arch Clin Exp Ophthalmol. 2007;245(9):1267-1271. doi:10.1007/s00417-006-0441-0. PMID:17265030.
Hokazono Y, Umezawa H, Kurokawa Y, Ogawa R. Optic Canal Decompression with a Lateral Approach for Optic Nerve Injury Associated with Traumatic Optic Canal Fracture. Plast Reconstr Surg Glob Open. 2019;7(10):e2489. doi:10.1097/GOX.0000000000002489. PMID:31772908.
Cockerham GC, Goodrich GL, Weichel ED, Orcutt JC, Rizzo JF, Bower KS, Schuchard RA. Eye and visual function in traumatic brain injury. J Rehabil Res Dev. 2009;46(6):811-818. PMID: 20104404↩↩2
Bernardo-Colón A, Vest V, Cooper ML, Naguib SA, Calkins DJ, Rex TS. Progression and Pathology of Traumatic Optic Neuropathy From Repeated Primary Blast Exposure. Front Neurosci. 2019;13:719. PMID: 31354422↩↩2
Lemke S, Cockerham GC, Glynn-Milley C, Cockerham KP. Visual quality of life in veterans with blast-induced traumatic brain injury. JAMA Ophthalmol. 2013;131(12):1602-1609. PMID: 24136237↩↩2
Mohan K, Kecova H, Hernandez-Merino E, Kardon RH, Harper MM. Retinal ganglion cell damage in an experimental rodent model of blast-mediated traumatic brain injury. Invest Ophthalmol Vis Sci. 2013;54(5):3440-3450. PMID: 23620426 / PMCID: PMC4597486↩
Kashkouli MB, Pakdel F, Sanjari MS, Haghighi A, Nojomi M, Homaee MH, Heirati A. Erythropoietin: a novel treatment for traumatic optic neuropathy-a pilot study. Graefes Arch Clin Exp Ophthalmol. 2011;249(5):731-736. PMID: 20890611↩
Naguib SA, Bernardo-Colón A, Rex TS. Intravitreal injection worsens outcomes in a mouse model of indirect traumatic optic neuropathy from closed globe injury. Exp Eye Res. 2020;202:108369. PMID: 33238184 / PMCID: PMC8117180↩
Thomas CN, Bernardo-Colón A, Courtie E, Essex G, Rex TS, Blanch RJ, Ahmed Z. Effects of intravitreal injection of siRNA against caspase-2 on retinal and optic nerve degeneration in air blast induced ocular trauma. Sci Rep. 2021;11(1):16839. PMID: 34413361↩
Copy the article text and paste it into your preferred AI assistant.
Article copied to clipboard
Open an AI assistant below and paste the copied text into the chat box.